AbbVie Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest AbbVie careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

Senior Manager, Immunology, U.S. Public Affairs **New** **USA, Illinois, Lake County** at Communications at http://abbvie.referrals.selectm...
Posted: February 22, 2018, 5:28 am
Senior Manager, Talent Management **New** **USA, Illinois, Lake County** at Human Resources at
Posted: February 22, 2018, 5:28 am
Senior Asset Management Analyst **New** **USA, Illinois, Lake County** at Information Technology at
Posted: February 22, 2018, 5:28 am
Cashier/Servicer **New** **USA, Illinois, Lake County** at Human Resources at
Posted: February 22, 2018, 5:28 am
Immunology Specialty Representative, Gastroenterology - Alexandria, VA **New** **USA, Virginia, Alexandria** at Sales at http://abbvie.refe...
Posted: February 22, 2018, 5:28 am

Viewing page 1 of 100|Next Page

  Newsfeed | Subscribe  

Voyager Therapeutics (VYGR) continued rocketing for a second day Wednesday after announcing a collaboration with AbbVie (ABBV) to develop an Alzheimer's disease drug — a deal that could lead to other neurodegenerative disease treatments, analysts ...
Posted: February 21, 2018, 2:52 pm
AbbVie (NYSE:ABBV) and Voyager Therapeutics, Inc. (NASDAQ:VYGR) are big movers in the biotechnology space during the middle of this week, with the two companies putting out some potentially game-changing news (and the news is interrelated – more o...
Posted: February 21, 2018, 11:14 am
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here. AbbVie (NYSE: ABBV), a global research and development-based biopharmaceutical company, in cooperation with Neurocrine Biosciences, Inc. (NASDAQ: NBIX), announce...
Posted: February 21, 2018, 5:07 am
Heron is worth buying at dips. Aimmune’s lead product candidate succeeds in late-stage study. Voyager and AbbVie sign exclusive agreement. Today we will discuss Heron Therapeutics (HRTX), which got a boost last week after an FDA Ad Com voted again...
Posted: February 21, 2018, 5:01 am
AbbVie Inc. ABBV, -0.52% and Neurocrine Biosciences Inc. NBIX, -0.79% shares rose 1.7% and 1.1% respectively in premarket trade Wednesday after the companies announced that their drug met its primary endpoint in a phase 3 trial testing it in women...
Posted: February 21, 2018, 4:34 am

Viewing page 1 of 2|Next Page